Program

Friday

  • Time
  • Topic/Speaker


    • Welcome

  • 8:00 am – 8:05 am
  • Opening Remarks
    Sanjiv S. Agarwala, MD
    • Breakfast Program

  • 8:05 am – 9:05 am
  • Educational program with breakfast available
    • Melanoma: Diagnosis and Beyond

      Moderator: Allan C. Halpern, MD, MSc
  • 9:05 am – 9:10 am
  • Pretest
    Allan C. Halpern, MD, MSc
  • 9:10 am – 9:25 am
  • Professional Diagnosis: How Hard to Look and with Which Technology (If Any)
    Allan C. Halpern, MD, MSc
  • 9:25 am – 9:40 am
  • Self-diagnosis: Consumer Dermoscopy
    Suraj S. Venna, MD
  • 9:40 am – 9:55 am
  • Screening for Melanoma
    Axel Hauschild, MD
  • 9:55 am – 10:10 am
  • Chemo Prevention: Melanoma Risk and Nutrition
    Martin A. Weinstock, MD, PhD
  • 10:10 am – 10:25 am
  • Clinical Follow-up in Patients with Melanoma
    Merrick I. Ross, MD
  • 10:25 am – 10:35 am
  • Questions and Answers
  • 10:35 am – 10:40 am
  • Posttest
    Allan C. Halpern, MD, MSc
    • Exhibit Hall Break

  • 10:40 am – 11:20 am
  • Join us for refreshments in the exhibit hall
    • Surgery and Adjuvant Therapy

      Moderator: Vernon K. Sondak, MD
  • 11:20 am – 11:25 am
  • Pretest/Case
    Vernon K. Sondak, MD
  • 11:25 am – 12:00 pm
  • Great Debate: Lymph Node Dissection for the Sentinel Node Positive Patient
  • Pro: Completion Lymphadenectomy is Still Standard of Care
    Vernon K. Sondak, MD
  • Con: Completion Lymphadenectomy is No Longer the Standard of Care
    Axel Hauschild, MD
  • 12:00 pm – 12:15 pm
  • Adjuvant Therapy for High Risk Melanoma: What's a Clinician To Do in 2016?
    Moderator: Sanjiv S. Agarwala, MD
  • Ipilimumab is the New Standard of Care
    Antonio C. Buzaid, MD
  • Interferon is Still the Standard
    Axel Hauschild, MD
  • 12:15 pm – 12:25 pm
  • Panel Discussion
  • 12:25 pm – 12:30 pm
  • Posttest
    Vernon K. Sondak, MD
  • 12:30 pm – 12:35 pm
  • Break
    • Lunch Program

  • 12:35 pm – 1:35 pm
  • Educational program while lunch is served
  • 1:35 pm – 1:40 pm
  • Break
    • Intralesional and Regional Therapy

      Moderator: Sanjiv S. Agarwala, MD
  • 1:40 pm – 1:45 pm
  • Pretest
    Sanjiv S. Agarwala, MD
  • 1:45 pm – 2:15 pm
  • Debate: Intralesional Monotherapy: Is There a Role?
    Yes: Merrick I. Ross, MD
    No: Robert H.I. Andtbacka, MD, CM, FACS, FRCSC
  • 2:15 pm – 2:30 pm
  • Current Trials with Oncolytic Agents
    Sanjiv S. Agarwala, MD
  • 2:30 pm – 2:40 pm
  • Panel Discussion and Posttest
    Sanjiv S. Agarwala, MD
    • Targeting the Immune System: Making Sense of it for the Clinician

      Moderator: Axel Hauschild, MD
  • 2:40 pm – 2:45 pm
  • Pretest
  • 2:45 pm – 3:15 pm
  • Great Debate: Combination Check-point Blockade It is the New Standard for All Patients
    Steven J. O'Day, MD
  • Still Not for Everybody
    Jeffrey S. Weber, MD, PhD
  • 3:15 pm – 3:30 pm
  • Biomarkers in Immunotherapy: Will They Help Us in Melanoma?
    Janice M. Mehnert, MD
  • 3:30 pm – 3:45 pm
  • New Check-point Targets in Melanoma: Current Status
    Christian Blank, MD, PhD
  • 3:45 pm – 3:50 pm
  • Posttest
    • Exhibit Hall Break

  • 3:50 pm – 4:30 pm
  • Join us for refreshments in the exhibit hall
    • Clinical (and Non-clinical) Conundrums of the Year

      Moderator: Richard D. Carvajal, MD
  • 4:30 pm – 4:35 pm
  • Pretest/Case
  • 4:35 pm – 4:50 pm
  • Practical Strategies to Lower the Cost of Metastatic Melanoma Treatment
    Nikhil I. Khushalani, MD
  • 4:50 pm – 5:05 pm
  • Adnexal Primary or Metastatic Carcinoma
    Jane L. Messina, MD
  • 5:05 pm – 5:20 pm
  • What's New in Uveal Melanoma
    Richard D. Carvajal, MD
  • 5:20 pm – 5:45 pm
  • Managing Brain Metastases in 2016
    Sanjiv S. Agarwala, MD
    • Meet the Faculty Reception and Poster Presentations

  • 5:45 pm – 6:45 pm
  • Mingle with faculty and colleagues in the exhibit hall while you view the latest melanoma research conducted by fellow attendees. Light appetizers and drinks will be available.
    This portion of the meeting is not approved for AMA PRA Category 1 Credit(s)™.